Remote Patient Monitoring Needs a Human Factor

Digital health devices have expanded what we can measure. The next RPM evolution is expanding function, adherence, and impact. 

The First Era of Remote Monitoring Was About Devices. The Next Era Is About People.

Remote patient monitoring (RPM) has made enormous strides over the past decade. Connected devices, mobile data, and digital dashboards have brought clinical information out of the exam room and into daily life. It’s an important achievement — and it has accelerated care delivery, expanded access, and reduced the need for constant site visits.

But as digital health has matured, a quieter reality has emerged:

RPM works in theory far more often than it works in practice.

Devices can collect data.

Dashboards can visualize it.

But patients — real humans with real routines — are the ones who determine whether monitoring actually happens.

And that reality introduces a set of variables that traditional RPM hasn’t fully addressed:

comfort, usability, identity, compliance, and daily dignity.

Why Remote Monitoring Struggles in the Real World

Talk to digital health teams, med-tech innovators, decentralized trial sponsors, or clinicians deploying RPM frameworks, and a pattern emerges. The challenges are no longer technical — they’re human:

• Device abandonment

• Protocol friction

• Poor adherence over time

• Caregiver burden

• Discomfort or stigma

• Insufficient patient context

• Limited functional data

Most of these breakdowns happen outside the clinic — in kitchens, workplaces, showers, stairwells, and bedrooms. In other words, in daily life.

The industry doesn’t have a technology problem.It has a human fit problem.

And in an era of decentralized trials, digital biomarkers, real-world evidence (RWE), and value-based care, adoption is no longer a “nice to have.” 

It’s a compliance variable.

It’s a data integrity variable.

It’s a risk reduction variable.

From Vital Signs to Functional Signals

RPM devices have done well with early, easily measurable signals:

• Heart rate

• Blood pressure

• Sleep patterns

• Oxygen saturation

These are important inputs — but they only capture a narrow slice of real-world health.

For many therapy areas, functional outcomes matter just as much:

• Gait and balance

• Strength

• Dexterity

• Task performance

• Fine motor control

• Movement frequency

• Adherence behaviors

• Therapy use patterns

  
  

These are the types of signals that influence:

• Quality of life

• Safety

• Fall risk

• Caregiver burden

• Therapeutic dosing

• Disease progression

• Clinical decision making

And increasingly, they are the types of endpoints that decentralized trials and digital biomarker frameworks need in order to mature.

Yet they require something the first generation of RPM didn’t optimize for:sustained, real-world participation.

Want to learn more about wearables and RPM

Download the our white paper on the the TechStylesLabs approach to wearable infrastructure and remote patient monitoring.

Learn More

Digital Biomarkers and the Rise of Real-World Data

Life sciences innovation is moving toward continuous, contextual, and ecological data — not just episodic snapshots.

Two macro shifts are driving this:

1. Decentralized & Hybrid Trials

Clinical trials no longer assume the site is the center of the universe. That relocation opens the door for:

• More diverse recruitment

• Reduced travel burden

• Lower protocol dropout

• More representative data
  

…but only if measurement can follow the patient into daily life.

2. Digital Biomarkers & Endpoints

As digital endpoints gain regulatory momentum, sponsors are seeking data that can:

• Quantify functional capacity

• Detect subtle progression

• Measure therapy impact

• Validate patient-reported outcomes (PROs)

• Support payer evidence packages
  

These require a fidelity that is hard to achieve with intermittent, device-only RPM.

To get there, the field needs interfaces that meet patients where they already are.

Why Clothing is a Natural Monitoring Interface

People don’t wake up and decide whether they will wear clothing today.Clothing is already integrated into daily living, identity, and routine.

This makes it a compelling candidate for clinical data collection because it brings:

Low stigma Clothing blends into daily life without signaling “patient” or “device.”

High adoption Users don’t have to remember to wear it — they already do.

High compliance

No extra steps, no extra burden, no extra training.

Real-world fidelity

Clothing captures movement, function, and behavior with ecological validity.

Large surface area

Different garments enable different sensing opportunities without stacking devices on the body.

This isn’t hypothetical. It’s the same logic that helped continuous glucose monitoring succeed: remove friction, eliminate stigma, reduce protocol burden.

In environments where adoption drives data — empathy is an infrastructure choice.

Empathy Isn’t Soft — It’s a Compliance Strategy

Empathy is sometimes dismissed as a soft value or a design aesthetic. In regulated health environments, it is neither.

Empathy is a way of anticipating failure modes before they happen:

• Why might a patient stop using it?

• How does it feel on the body?

• Does it signal illness or identity?

• Does it require caregiver assistance?

• Does it add or remove dignity?

• Is it compatible with daily life?
  

Every one of those questions maps directly to:

Adherence Abandonment Caregiver burden Protocol performance Data integrity RWE validity Health economics

Empathy reduces risk by reducing dropout.

Empathy increases evidence by increasing participation.

Empathy strengthens outcomes by strengthening adoption.

It is not an emotion. It is an operating system for compliance.

Patients Are the Experts in Their Own Experience

Clinicians diagnose. Engineers design. Pharma develops molecules.But patients are the only ones who know what it’s like to live inside the therapy.

When the goal is real-world use, patients become the expert input.

Not as anecdotes. Not as testimonials. But as design constraints.

Listening to patients improves care. Building with patients improves evidence. Designing for patients improves scale.

The Next Layer of Digital Health is Wearable Infrastructure

We are entering a phase where wearables are no longer gadgets — they are data infrastructure for:

• Decentralized trials

• RWE generation

• Digital endpoints

• Disease progression models

• Payer evidence

• Caregiver support

• Clinical decision support

The challenge is not the technology. The challenge is designing for real-world adoption.

And that is where clothing, adaptive interfaces, and wearable health products are poised to unlock the next generation of RPM.

Where This Goes Next

We don’t believe the future of patient monitoring is device-less.We believe it is human-first.

The devices will continue to evolve.

The dashboards will continue to refine.

But the real breakthrough will be closing the gap between:

Because in the end, the only monitoring that matters is the monitoring that happens.

–

At TechStyle Labs, we are exploring this emerging layer — where empathy, human factors, biomechanics, and digital health converge to make remote monitoring more functional, more contextual, and more adoptable.

If you're interested in where the field is heading, we’ll continue sharing what we’re learning as the category matures.